Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62
Rowena DeJesus(Novartis (United States)), Beat Nyfeler(Novartis (Switzerland)), Guglielmo Roma(Novartis (Switzerland)), Walter Carbone(Novartis (Switzerland)), John Reece-Hoyes(University of Massachusetts Chan Medical School), Shanming Liu(Pathways Behavioral Services), Judith Knehr(Novartis (Switzerland)), Jennifer Kelliher(Pathways Behavioral Services), John Alford(The University of Melbourne), Gregory McAllister, Martin Beibel(Novartis (Switzerland)), Aylwin Ng(Broad Institute), Craig Mickanin, Ramnik J. Xavier(Massachusetts General Hospital), John A. Tallarico(Harvard University), Alicia Lindeman, Zuncai Wang(Pathways Behavioral Services), Jeffery A. Porter(Curis (United States)), Gregory R. Hoffman, Phil Bergman(Novartis (United States)), Carsten Russ(Broad Institute), Francesca Moretti(Novartis (Switzerland)), Leon O. Murphy(Casma Therapeutics (United States)), Elizabeth Frias(Novartis (United States))
Cited by 156
Related Papers
A Draft Sequence of the Neandertal Genome
|Science|2010|4.6k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k